A Phase IV Study to Assess the Safety of EupentaTM Inj
NCT04056728
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
3000
Enrollment
INDUSTRY
Sponsor class
Conditions
Hepatitis B
Diphtheria
Haemophilus Influenzae Type B Infection
Tetanus
Pertussis
Interventions
BIOLOGICAL:
Eupenta Inj.
Sponsor
LG Chem